Author

H.-M. Jäck

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 2 Assay:proteomics· 2 Organism:mouse· 1

Frequent Co-Authors

A. Cossmann· 1 shared A. Dopfer-Jablonka· 1 shared A. G. Stewart· 1 shared A. Kelleher· 1 shared A. Kempf· 1 shared A.-S. Moldenhauer· 1 shared B. Hudson· 1 shared C. Goodnow· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Cossmann

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients

R. Rouet, J. Y. Henry, M. D. Johansen, M. Sobti, H. Balachandran, D. B. Langley, G. Walker, H. Lenthall, J. Jackson, S. Ubiparipovic, O. Mazigi, P. Schofield, D. L. Burnett, S. H. J. Brown, M. Martinello, , D. Christ

This paper isolates broadly neutralizing SARS-CoV-2 antibodies from convalescent patients and shows they neutralize emerging variants more effectively than existing monoclonal antibodies.

bioRxiv · Oct 19, 2022Immunology

The microRNA processing subunit DGCR8 is required for a T cell-dependent germinal center response

D. Patrick, J. Meinzinger, S. R. Schulz, J. Corte-Real, M. Hauke, E. Roth, W. Schuh, D. Mielenz, J. Wittmann, H.-M. Jäck, K. Pracht

This study shows that DGCR8 is essential for T cell-dependent germinal center responses and antibody production, but not for B-1 cell functions.

bioRxiv · Jul 31, 2022Immunology

The Omicron variant is highly resistant against antibody-mediated neutralization - implications for control of the COVID-19 pandemic

M. Hoffmann, N. Krüger, S. Schulz, A. Cossmann, C. Rocha, A. Kempf, I. Nehlmeier, L. Graichen, A.-S. Moldenhauer, M. S. Winkler, M. Lier, A. Dopfer-Jablonka, H.-M. Jäck, G. Behrens, S. Pöhlmann

This study shows the Omicron variant is highly resistant to antibody neutralization, reducing effectiveness of current therapies and vaccines.

bioRxiv · Dec 12, 2021Microbiology